Advisory: News alert on Bone Therapeutics mid-term target withdrawn
Sept 24 (Reuters) - Please be advised that the alert on Bone Therapeutics mid-term growth potential is wrong and has been withdrawn. The alert was issued in error from a press release of an unrelated company. STORY_NUMBER: FWN1WA02W STORY_DATE: 24/09/2018 STORY_TIME: 05:01:39 (Gdynia Newsroom) ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Biosenic SA
See all newsBrief: Biosenic Says Enterprise Court Of Nivelles Approves Co's Restructuring Plan
Brief: Biosenic Anticipates Having Sufficient Cash To Carry Out Its Business Objectives Until Q3 2024
Brief: BioSenic Patent Granted In Canada For Broader Protection Of ATO Therapeutic Platform
Brief: Biosenic Files For Additional Patent Protection For Osteoarthritis Drug
Brief: BioSenic Signs New Binding Term Sheet With Phebra PTY Ltd